Background: Confirmatory tests are recommended for diagnosing primary aldosteronism,
but the supporting evidence is unclear. Methods: We searched Medline, EMBASE, and the …

In this review, we propose a management approach that considers the specific effects of
antihypertensive medications on the RAAS axis and the patient's disease phenotype. Based …

Objective Primary aldosteronism (PA) is the most common surgically curable cause of
hypertension. Unilateral aldosterone-producing adenoma can be treated with …

Context The diagnostic work-up of primary aldosteronism (PA) includes screening and
confirmation steps. Case confirmation is time-consuming, expensive, and there is no …

Background The systematic use of confirmatory tests in the diagnosis of primary
aldosteronism (PA) increases costs, risks and complexity to the diagnostic work-up. In light …

Context The current clinical guidelines suggest that confirmatory tests for primary
aldosteronism (PA) may be excluded in some of patients who have elevated plasma …

Context Current clinical guidelines recommend confirmation of a positive result in at least
one confirmatory test in the diagnosis of primary aldosteronism (PA). Clinical implication of …

Objective Saline infusion testing (SIT) for confirmation of primary aldosteronism (PA) is
based on impaired aldosterone suppression in PA compared to essential hypertension (EH) …

Captopril challenge test (CCT) is a simple and safe confirmatory test for primary
aldosteronism (PA). We investigated the effectiveness of the indices after captopril …

卡托普利试验对原发性醛固酮增多症诊断价值的初步探讨- PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …